Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 27 most recent Form 4 transactions.
| $125.8K |
| -9.0% |
| Open the original filing on SEC.gov |
| Apr 27 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 5,500 | $3.79 | $20.8K | +10.0% | Open the original filing on SEC.gov |
| Mar 25 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 5,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 25 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 5,500 | $18.95 | $104.2K | -9.0% | Open the original filing on SEC.gov |
| Mar 25 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 5,500 | $3.79 | $20.8K | +10.0% | Open the original filing on SEC.gov |
| Mar 4 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 16,300 | — | — | — | Open the original filing on SEC.gov |
| Mar 4 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 16,300 | $18.52 | $301.9K | -22.8% | Open the original filing on SEC.gov |
| Mar 4 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 16,300 | $3.79 | $61.8K | +29.5% | Open the original filing on SEC.gov |
| Mar 3 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 200 | — | — | — | Open the original filing on SEC.gov |
| Mar 3 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 200 | $18.45 | $3.7K | -0.4% | Open the original filing on SEC.gov |
| Mar 3 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 200 | $3.79 | $758 | +0.4% | Open the original filing on SEC.gov |
| Feb 2 | BCAX | Bicara Therapeutics Inc. | AGRANT◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 26, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◆ | 19,789 | — | — | — | Open the original filing on SEC.gov |
| Dec 26, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER | 19,789 | $3.79 | $75K | +55.8% | Open the original filing on SEC.gov |
| Nov 25, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 906 | — | — | — | Open the original filing on SEC.gov |
| Nov 25, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 4,594 | — | — | — | Open the original filing on SEC.gov |
| Nov 25, 2025 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 906 | $18.84 | $17.1K | -2.5% | Open the original filing on SEC.gov |
| Nov 25, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 906 | $3.79 | $3.4K | +2.5% | Open the original filing on SEC.gov |
| Nov 25, 2025 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 4,594 | $18.84 | $86.6K | -11.5% | Open the original filing on SEC.gov |
| Nov 25, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 4,594 | $3.79 | $17.4K | +12.9% | Open the original filing on SEC.gov |
| Nov 24, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 5,500 | — | — | — | Open the original filing on SEC.gov |
| Nov 24, 2025 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 5,500 | $18.45 | $101.5K | -13.4% | Open the original filing on SEC.gov |
| Nov 24, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 5,500 | $3.79 | $20.8K | +15.5% | Open the original filing on SEC.gov |
| Oct 9, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷◆ | 22,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 9, 2025 | BCAX | Bicara Therapeutics Inc. | SSELL◷ | 22,000 | $18.45 | $405.9K | -38.3% | Open the original filing on SEC.gov |
| Oct 9, 2025 | BCAX | Bicara Therapeutics Inc. | MEXER◷ | 22,000 | $3.79 | $83.4K | +62.0% | Open the original filing on SEC.gov |